Clindamycin Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Clindamycin Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

WARNING





CLINDAMYCIN HYDROCHLORIDE DESCRIPTION



DESCRIPTION



Clindamycin Hydrochloride





CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY

Human Pharmacology







MICROBIOLOGY

Microbiology





























SUSCEPTIBILITY TESTING METHODS



Dilution Techniques


Diffusion Techniques

Table 1. Susceptibility Interpretive Criteria for Clindamycin
SusceptibilityInterpretiveCriteriaMinimalDiskInhibitoryDiffusionPathogenConcentrations(Zone(MIC inDiameters
mcg/mL)in mm)







Quality Control

Table 2. Acceptable Quality Control Ranges for Clindamycin to be Used in Validation of Susceptibility Test Results
AcceptableQualityControl RangesQC StrainMinimumDiskInhibitoryDiffusionConcentrations(Zone(MIC in Diametersmcg/mL)in mm)








INDICATIONS & USAGE

INDICATIONS AND USAGE









CLINDAMYCIN HYDROCHLORIDE CONTRAINDICATIONS

CONTRAINDICATIONS


WARNINGS

WARNINGS







PRECAUTIONS

PRECAUTIONS

General








INFORMATION FOR PATIENTS

Information for Patients


LABORATORY TESTS

Laboratory Tests


DRUG INTERACTIONS

Drug Interactions



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

Carcinogenesis, Mutagenesis, Impairment of Fertility



PREGNANCY

Teratogenic effects

Pregnancy category B



NURSING MOTHERS

Nursing Mothers


PEDIATRIC USE

Pediatric Use


GERIATRIC USE

Geriatric Use



CLINDAMYCIN HYDROCHLORIDE ADVERSE REACTIONS

ADVERSE REACTIONS









OVERDOSAGE

OVERDOSAGE




DOSAGE & ADMINISTRATION

DOSAGE AND ADMINISTRATION






HOW SUPPLIED











STORAGE AND HANDLING



ANIMAL PHARMACOLOGY & OR TOXICOLOGY

ANIMAL TOXICOLOGY


REFERENCES












INACTIVE INGREDIENT



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Clindamycin Hydrochloride

Clindamycin Hydrochloride

Clindamycin Hydrochloride

Clindamycin Hydrochloride CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-707(NDC:63304-692-05)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CLINDAMYCIN HYDROCHLORIDE clindamycin 150 mg

Inactive Ingredients

Ingredient Name Strength
titanium dioxide
talc
MAGNESIUM STEARATE
lactose monohydrate
GELATIN
FD&C BLUE NO. 1
D&C YELLOW NO. 10
STARCH, CORN

Product Characteristics

Color Size Imprint Code Shape
turquoise 19 mm RX692 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-707-05 21 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065061 2011-04-06


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.